|drug1707||Interview by psychologists Wiki||1.00|
|D002659||Child Development Disorders, Pervasive NIH||0.71|
|D001289||Attention Deficit Disorder with Hyperactivity NIH||0.58|
There is one clinical trial.
The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.
Description: Patients chance of clinical deterioration of COVID19 disease as defined by percentage of patients requiring oxygen therapy during their hospitalization.Measure: Clinical deterioration Time: 14 days
Description: NEWS2- National Early Warning Score - a score defining the probability of severe COVID 19 disease. Minimum score is 0, while maximum score is 23. Higher score means worse outcomeMeasure: Changes in NEWS scale Time: 14 days
Description: Percentage of patients requiring the respiratory support of either of the following : high flow nasal canula oxygen support, mechanical ventilation or use of extra corporeal membrane oxygenation.Measure: Supportive care therapies Time: 14 days
Description: Presence of SARS-COV2 in oral & nasal secretions in days 10, 14 of the studyMeasure: SARS-COV2 presence Time: 10 days, 14 days
Description: Hospitalization days due to COVID-19Measure: Hospitalization Days Time: 14 days
Description: IL2, IL18, IL8. IL6, IL10, TNF-alpha, TGF-beta levels at day 3, day 7 and discharge day (which is on average the 10th day of hospitalization). All cytokine levels would be measured by pg/mL.Measure: Cytokine Levels Time: Day 3, day 7, discharge day (which is on average the 10th day of hospitalization).
Description: A verified score measuring anxiety. Minimum score is 0, while maximum score is 56. Higher scores mean worse outcome.Measure: Hamilton Anxiety Score Time: 14 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports